TAT-PiET
TAT-PiET is a cell-penetrating peptide targeting the extra-terminal (ET) domain of BRD4. TAT-PiET can reduce BRD4 and JMJD6 levels and inhibit cell proliferation. TAT-PiET also resists the endocrine resistance of ERα-positive breast cancer cells. TAT-PiET can be used for the research of cancer, such as breast cancer.
商品は「研究用試薬」です。人や動物の医療用・臨床診断用・食品用の製品ではありません。
研究用途以外に使用した場合、当社は一切の責任を負いかねます。
- CAS 番号: 3036046-03-1
- 分子式: C110H192N48O27S
- 分子量:2651.07
-
保管条件:
Please store the product under the recommended conditions in the Certificate of Analysis.
生物活性
|
BRD4 |
TAT-PiET inhibits proliferation in MCF7, T47D, MDA-MB231, and BT549 cell with EC50 values of 8.13, 13.35, 4.68 and 32.34 μM[1].
TAT-PiET (10 μM) inhibits colony formations in MCF7 and MDA-MB231 cells
TAT-PiET (10 μM) inhibits migration in MCF7 and MDA-MB231 cells
TAT-PiET (10 μM, 6 h) decreases expression of c-Myc, N-myc, and CCND1 in MCF7 and MDA-MB-231 cells
TAT-PiET (10 μM) increases sensitivities in Tamoxifen (HY-13757A) -resistant MCF7 and T47Dcells[1].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Cell Line:MCF7 and MDA-MB-231 cells
-
Concentration:10 μM
-
Incubation Time:6 h
-
Result:Decreased expression of c-Myc, N-myc, and CCND1.
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Animal Model:MCF7/MDA-MB231 tumor mice models[1]
-
Dosage:25 mg/kg
-
Administration:Intraperitoneally injection, every 2 days
-
Result:Reduced tumor volume and weight.
Reduced BRD4 and JMJD6 levels.
Reduced c-Myc, N-myc, and CCND1 levels.
化学情報
-
CAS 番号 3036046-03-1
-
分子量 2651.07
-
分子式 C110H192N48O27S
-
配列
Tyr-Gly-Arg-Lys-Lys-Arg-Arg-Gln-Arg-Arg-Arg-Arg-Asn-Gln-Lys-Phe-Lys-Cys-Gly-Glu
-
シーケンスの短縮
YGRKKRRQRRRRNQKFKCGE
-
輸送条件
Room temperature in continental US; may vary elsewhere.
-
保管条件
Please store the product under the recommended conditions in the Certificate of Analysis.
純度とドキュメンテーション
参考文献
Calculators
濃度 (開始) × 体積 (開始) = 濃度 (終了) × 体積 (終了)